Skip to main content
. 2018 Mar 22;14(1):59–66. doi: 10.5114/aic.2018.74356

Table II.

Adverse events at 6-month follow-up

Adverse events Placebo group N = 110 NAC group N = 102 P-value
Death (all causes): 2 (1.8%) 4 (3.9%) NS
CV 1 (0.9%) 1 (0.9%) NS
Other 1 (0.9%) 3 (2.6%) NS
MI 2 (1.8%) 3 (2.6%) NS
Dialysis 1 (0.9%) 0 (0%) NS
Rehospitalization (cardiac causes) 20 (18.1%) 16 (15.7%) NS
Rehospitalization (renal causes) 3 (2.7%) 2 (2.0%) NS

NAC – N-acetylcysteine, CV – cardiovascular, MI – myocardial infarction.